Page 1: NorPedMed – Norway’s National Infrastructure for Pediatric Clinical Trials
NorPedMed is Norway’s national infrastructure for pediatric clinical trials. Established in 2013, NorPedMed facilitates Norway’s participation in international efforts to give children access to safe, effective, and innovative treatments. NorPedMed strengthens national capacity, ensures that pediatric trial activities align with global standards, and serves as a reliable single point of entry for international sponsors.
NorPedMed reflects Norway's strong commitment to improving the global evidence base for pediatric medicine, ensuring that children receive the same standard of research-based care as we expect to find in the adult world.
Children have historically been underrepresented in medical research. NorPedMed addresses this challenge by coordinating Norway’s national infrastructure for pediatric clinical trials and ensuring alignment with international ethical, scientific, and regulatory standards.
NorPedMed is a full member of the European pediatric research ecosystem through its role in EU initiatives such as NordicPedMed, conect4children (c4c), and Enpr-EMA. As such, NorPedMed offers a reliable single point of entry for international sponsors looking to engage with Norwegian and Nordic trial capacity within a harmonized European framework.